{{Infobox_gene}}
'''非受体酪氨酸激酶2'''（{{lang-en|Non-receptor tyrosine-protein kinase}}，'''TYK2'''） 是人类基因组中''TYK2''[[基因|基因]]所编码的[[酶|酶]]<ref name="pmid2156206">{{cite journal | author = Krolewski JJ, Lee R, Eddy R, Shows TB, Dalla-Favera R | title = Identification and chromosomal mapping of new human tyrosine kinase genes | journal = Oncogene | volume = 5 | issue = 3 | pages = 277–82 | pmid = 2156206 | doi = | url =https://archive.org/details/sim_oncogene_1990-03_5_3/page/277| issn = |date=March 1990}}</ref><ref name="entrez">{{cite web| title = Entrez Gene: TYK2 tyrosine kinase 2| url = http://www.ncbi.nlm.nih.gov/sites/entrez?Db=gene&Cmd=ShowDetailView&TermToSearch=7297| accessdate = | archive-date = 2019-06-14| archive-url = https://web.archive.org/web/20190614072427/https://www.ncbi.nlm.nih.gov/gene?Db=gene&Cmd=ShowDetailView&TermToSearch=7297| dead-url = no}}</ref>。

TYK2是[[JAK激酶|JAK]]家族中第一个被报导的（该家族的其它成员有[[JAK激酶1|JAK1]]、[[JAK激酶2|JAK2]]和[[JAK激酶3|JAK3]]）<ref name="pmid9759489">{{cite journal | author = Stark GR, Kerr IM, Williams BR, Silverman RH, Schreiber RD | title = How cells respond to interferons | journal = Annu. Rev. Biochem. | volume = 67 | issue = 1| pages = 227–64 | year = 1998 | pmid = 9759489 | doi = 10.1146/annurev.biochem.67.1.227 | url =  }}</ref>，与[[干扰素|干扰素]]α、[[白细胞介素6|IL-6]]、[[白细胞介素10|IL-10]]和[[白细胞介素12|IL-12]]的信号相关。

==功能==
酪氨酸激酶2是''TYK2''[[基因|基因]]编码的[[酪氨酸激酶|酪氨酸激酶]]中[[JAK激酶|JAK激酶]]家族（JAKs）的一个成员蛋白。该蛋白与I型或II型[[细胞因子受体|细胞因子受体]]的胞质结构域结合，并通过磷酸化受体亚基来传递细胞因子的信号。该酶参与[[干扰素|干扰素]]α和β产生的信号通路，因此也可能在抗病毒免疫中扮演一个角色<ref name="entrez"/>。

细胞因子通过调节免疫细胞以及其它系统的细胞的存活、增殖、分化以及功能在免疫与炎症中起关键作用<ref name="isbn0-19-859947-1">{{cite book | author = Nicola, Nicos | authorlink = | editor = | others = | title = Guidebook to cytokines and their receptors | edition = | language = | publisher = Oxford University Press | location = Oxford [Oxfordshire] | year = 1994 | origyear = | pages = | quote = | isbn = 0-19-859947-1 | oclc = | doi = | url = | accessdate = }}</ref>。因此，以细胞因子及其受体为靶标是治疗这类疾病的有效手段。[[白细胞介素|白细胞介素]]、[[干扰素|干扰素]]和[[促红细胞生成素|促红细胞生成素]]等细胞因子正是通过I型和II型细胞因子受体与JAK家族的激酶结合来传递胞内信号。<ref name="pmid14639467">{{cite journal | author = Kubo M, Hanada T, Yoshimura A | title = Suppressors of cytokine signaling and immunity | journal = Nat. Immunol. | volume = 4 | issue = 12 | pages = 1169–76 | pmid = 14639467 | doi = 10.1038/ni1012 | url =  |date=December 2003}}</ref>

哺乳动物的JAK激酶家族拥有四个成员：JAK1、JAK2、JAK3和酪氨酸激酶2（TYK2）<ref name="pmid9759489"/>。Jak激酶和细胞因子信号之间关系的第一次阐明是在筛选{{link-en|I型干扰素|interferon type I}}（IFN-1）信号相关基因时，鉴别出Tyk2是[[细胞因子受体|细胞因子受体]]进行一系列激活必要组件<ref name="pmid1386289">{{cite journal | author = Velazquez L, Fellous M, Stark GR, Pellegrini S | title = A protein tyrosine kinase in the interferon alpha/beta signaling pathway | journal = Cell | volume = 70 | issue = 2 | pages = 313–22 | pmid = 1386289 | doi = 10.1016/0092-8674(92)90105-L| url = |date=July 1992}}</ref>。而与早先在小鼠模型分析的基础上鉴定出的Tyk2对IL-12与I型干扰素信号的介导相比，Tyk2在人类基因组中的功能更为广泛和深刻。TYK2缺陷已在人类细胞中比在小鼠细胞的影响更大，在[[I型干扰素|干扰素α和β]]以及[[白细胞介素12|IL-12]]之外，Tyk2还对[[白细胞介素23|IL-23]]、[[白细胞介素10|IL-10]]以及[[白细胞介素6|IL-6]]信号的转导起重要作用。因此，对于与[[glycoprotein_130|gp-130受体]]链相结合的IL-6类细胞因子，包括IL-6、[[interleukin_11|IL-11]]、[[interleukin_27|IL-27]]、[[interleukin_31|IL-31]]、{{le|制瘤素|MOncostatin M}}（OSM）、{{le|睫状神经营养因子|ciliary neurotrophic factor}}、{{le|心肌营养素1|cardiotrophin 1}}、{{le|CLCF1|CLCF1|心肌营养素样细胞因子因子}}以及[[白血病抑制因子|LIF]]，Tyk2都具有信号传导作用。近来由发现了IL-12和IL-23在激活Tyk2的过程中使用了相同的配体与受体亚基。

IL-10是一个关键的抗炎性细胞因子，IL-10基因敲除的小鼠会遭受致命的全身性自體免疫性疾病。Tyk2由[[interleukin_10|IL-10]]激活它的缺乏会影响细胞生成和响应IL-10的能力<ref name="pmid16751369">{{cite journal | author = Shaw MH, Freeman GJ, Scott MF, ''et al'' | title = Tyk2 negatively regulates adaptive Th1 immunity by mediating IL-10 signaling and promoting IFN-γ-dependent IL-10 reactivation | journal = J. Immunol. | volume = 176 | issue = 12 | pages = 7263–71 | pmid = 16751369 | doi =  | url = http://www.jimmunol.org/cgi/pmidlookup?view=long&pmid=16751369 | issn =  | date = June 2006 | access-date = 2013-10-22 | archive-date = 2019-06-14 | archive-url = https://web.archive.org/web/20190614072423/http://www.jimmunol.org/content/176/12/7263.long | dead-url = no }}</ref>。在一般生理条件下，免疫细胞会受到许多种细胞因子的调节作用。现在已经清楚的是，这些不同的细胞因子信号在通过JAK–STAT信号通路时，会发生相互串扰<ref name="pmid11070174">{{cite journal | author = Shimoda K, Kato K, Aoki K, ''et al'' | title = Tyk2 plays a restricted role in IFN alpha signaling, although it is required for IL-12-mediated T cell function | journal = Immunity | volume = 13 | issue = 4 | pages = 561–71 | pmid = 11070174 | doi = 10.1016/S1074-7613(00)00055-8 | url = http://linkinghub.elsevier.com/retrieve/pii/S1074-7613(00)00055-8 | date = October 2000 | access-date = 2013-10-22 | archive-date = 2019-06-14 | archive-url = https://web.archive.org/web/20190614072426/https://linkinghub.elsevier.com/retrieve/pii/S1074-7613(00)00055-8 | dead-url = no }}</ref>。
== 炎症上的機制 ==

目前普遍認為[[动脉粥样硬化|动脉粥样硬化]]肇因於[[發炎現象|發炎現象]]中的分子与细胞变化<ref name="pmid9887164">{{cite journal | author = Ross R | last2 = Ross | first2 = Russell | title = Atherosclerosis--an inflammatory disease | journal = N. Engl. J. Med. | volume = 340 | issue = 2 | pages = 115–26 | pmid = 9887164 | doi = 10.1056/NEJM199901143400207| url =  |date=January 1999}}</ref>，而血管發炎可能是由[[血管收縮素|血管收縮素II]]（Angiotensin II）的表現增加所致。發炎的血管會在局部分泌{{en-link|白細胞介素6|Interleukin 6}}（Interleukin 6，IL-6），IL-6是一種[[細胞激素|細胞激素]]，會促進血管收縮素II合成及分泌，和透過[[JAK-STAT信號通路|JAK-STAT信號通路]]促進肝臟的[[血管新生|血管新生]]作用。

JAK/STAT3途徑會被目標細胞膜上的高親和性蛋白受體{{en-link|白細胞介素6受體|Interleukin-6 receptor}}（Interleukin-6 receptor，IL-6R）致活，參與這個連鎖反應的蛋白，包含了{{en-link|醣蛋白130|glycoprotein 130}}（glycoprotein 130，gp-130）和酪胺酸激酶（JAK1、JAK2和Tyk2）<ref name="pmid12171785">{{cite journal | author = Brasier AR, Recinos A, Eledrisi MS | title = Vascular inflammation and the renin-angiotensin system | journal = Arterioscler. Thromb. Vasc. Biol. | volume = 22 | issue = 8 | pages = 1257–66 | pmid = 12171785 | doi = 10.1161/01.ATV.0000021412.56621.A2| url =https://archive.org/details/sim_arteriosclerosis-thrombosis-and-vascular-biology_2002-08_22_8/page/1257|date=August 2002}}</ref>。

在慢性[[哮喘|哮喘]]患者的肺中，細胞因子[[白細胞介素4|白細胞介素4]]（Interleukin 4，IL-4）和{{en-link|白細胞介素13|Interleukin 13}}（Interleukin 13，IL-13）的濃度會升高。經由IL-4/IL-13複合物的信息途徑被認為是由{{en-link|白細胞介素6受體|interleukin-4 receptor}}（Interleukin-6 receptor，IL-4Rα），其中受體包含了JAK-1和Tyk2等激酶。<ref name="pmid10960667">{{cite journal | author = Wills-Karp M | title = Murine models of asthma in understanding immune dysregulation in human asthma | journal = Immunopharmacology | volume = 48 | issue = 3 | pages = 263–8 | pmid = 10960667 | doi = 10.1016/S0162-3109(00)00223-X| url = |date=July 2000}}</ref>

從缺乏Tyk2的小鼠（Tyk2<sup>-/-</sup>）身上，我們可以觀察到Tyk2對於[[类风湿性关节炎|類風溼性關節炎]]的發生所造成的影響<ref name="pmid14500783">{{cite journal | author = Shaw MH, Boyartchuk V, Wong S, Karaghiosoff M, Ragimbeau J, Pellegrini S, Muller M, Dietrich WF, Yap GS | title = A natural mutation in the Tyk2 pseudokinase domain underlies altered susceptibility of B10.Q/J mice to infection and autoimmunity | journal = Proc. Natl. Acad. Sci. U.S.A. | volume = 100 | issue = 20 | pages = 11594–9 | pmid = 14500783 | pmc = 208803 | doi = 10.1073/pnas.1930781100 | url =  |date=September 2003}}</ref>。Tyk2<sup>-/-</sup>的小鼠對於低劑量的[[干擾素|干擾素-α]] （IFN-α）缺乏反應性，但在高劑量的 IFN-α和IFN-β作用下，反應仍然是正常的<ref name="pmid11070174">{{cite journal | author = Shimoda K, Kato K, Aoki K, Matsuda T, Miyamoto A, Shibamori M, Yamashita M, Numata A, Takase K, Kobayashi S, Shibata S, Asano Y, Gondo H, Sekiguchi K, Nakayama K, Nakayama T, Okamura T, Okamura S, Niho Y, Nakayama K | title = Tyk2 plays a restricted role in IFN alpha signaling, although it is required for IL-12-mediated T cell function | journal = Immunity | volume = 13 | issue = 4 | pages = 561–71 | pmid = 11070174 | doi = 10.1016/S1074-7613(00)00055-8| url = |date=October 2000}}</ref><ref name="pmid11070173">{{cite journal | author = Karaghiosoff M, Neubauer H, Lassnig C, Kovarik P, Schindler H, Pircher H, McCoy B, Bogdan C, Decker T, Brem G, Pfeffer K, Müller M | title = Partial impairment of cytokine responses in Tyk2-deficient mice | journal = Immunity | volume = 13 | issue = 4 | pages = 549–60 | pmid = 11070173 | doi = 10.1016/S1074-7613(00)00054-6| url = |date=October 2000}}</ref>。另外，這些小鼠對於IL-6和IL-10的作用反應正常，可見Tyk2對於IL-6和IL-10的傳訊調節上市非必要的，且在IFN-α的傳訊上也並不是扮演非常主要的角色。

雖然Tyk2<sup>-/-</sup>的小鼠表型正常，但他們在發炎反應中仍然有許多不正常的症狀<ref name="pmid16982690">{{cite journal | author = Potla R, Koeck T, Wegrzyn J, Cherukuri S, Shimoda K, Baker DP, Wolfman J, Planchon SM, Esposito C, Hoit B, Dulak J, Wolfman A, Stuehr D, Larner AC | title = Tyk2 tyrosine kinase expression is required for the maintenance of mitochondrial respiration in primary pro-B lymphocytes | journal = Mol. Cell. Biol. | volume = 26 | issue = 22 | pages = 8562–71 | pmid = 16982690 | pmc = 1636766 | doi = 10.1128/MCB.00497-06 | url =https://archive.org/details/sim_molecular-and-cellular-biology_2006-11_26_22/page/8562|date=November 2006}}</ref>。最明顯的是這些小鼠的[[巨噬細胞|巨噬細胞]]不會受到[[脂多糖|脂多糖]]（Lipopolysaccharide，LPS）的刺激而釋放出[[一氧化氮|一氧化氮]]。對於這LPS信息傳送的分子機制，進一步的研究發現，Tyk2和IFN-β的缺失會阻抗脂多糖誘導[[內毒素|內毒素]]性休克（endotoxin shock），而[[STAT1|STAT1]]缺失的小鼠則比較容易受到感染<ref name="pmid12679810">{{cite journal | author = Karaghiosoff M, Steinborn R, Kovarik P, Kriegshäuser G, Baccarini M, Donabauer B, Reichart U, Kolbe T, Bogdan C, Leanderson T, Levy D, Decker T, Müller M | title = Central role for type I interferons and Tyk2 in lipopolysaccharide-induced endotoxin shock | journal = Nat. Immunol. | volume = 4 | issue = 5 | pages = 471–7 | pmid = 12679810 | doi = 10.1038/ni910 | url =  |date=May 2003}}</ref>。

Tyk2抑制劑的發展可能可以作為治療類風溼性關節炎的藥品<ref name="pmid16193102">{{cite journal | author = Thompson JE | title = JAK protein kinase inhibitors | journal = Drug News Perspect. | volume = 18 | issue = 5 | pages = 305–10 | pmid = 16193102 | doi = 10.1358/dnp.2005.18.5.904198 | url = | issn = |date=June 2005}}</ref>。

== 臨床上的重要性 ==
TYK2基因的突變與{{en-link|高免疫球蛋白E症候群|Hyper-IgE syndrome}}（Hyperimmunoglobulin E syndrome，HIES），一種造成血漿中免疫球蛋白[[IgE|IgE]]濃度不正常升高的疾病相关。<ref name="pmid17088085">{{cite journal | author = Minegishi Y, Saito M, Morio T, Watanabe K, Agematsu K, Tsuchiya S, Takada H, Hara T, Kawamura N, Ariga T, Kaneko H, Kondo N, Tsuge I, Yachie A, Sakiyama Y, Iwata T, Bessho F, Ohishi T, Joh K, Imai K, Kogawa K, Shinohara M, Fujieda M, Wakiguchi H, Pasic S, Abinun M, Ochs HD, Renner ED, Jansson A, Belohradsky BH, Metin A, Shimizu N, Mizutani S, Miyawaki T, Nonoyama S, Karasuyama H | title = Human tyrosine kinase 2 deficiency reveals its requisite roles in multiple cytokine signals involved in innate and acquired immunity | journal = Immunity | volume = 25 | issue = 5 | pages = 745–55 | pmid = 17088085 | doi = 10.1016/j.immuni.2006.09.009 | url = | issn = |date=November 2006}}</ref><ref name="pmid17098200">{{cite journal | author = Watford WT, O'Shea JJ | title = Human tyk2 kinase deficiency: another primary immunodeficiency syndrome | journal = Immunity | volume = 25 | issue = 5 | pages = 695–7 | pmid = 17098200 | doi = 10.1016/j.immuni.2006.10.007 | url = | issn = |date=November 2006}}</ref><ref name="pmid17989526">{{cite journal | author = Minegishi Y, Karasuyama H | title = Hyperimmunoglobulin E syndrome and tyrosine kinase 2 deficiency | journal = Curr Opin Allergy Clin Immunol | volume = 7 | issue = 6 | pages = 506–9 | pmid = 17989526 | doi = 10.1097/ACI.0b013e3282f1baea | url = | issn = |date=December 2007}}</ref>

==交互作用==
酪氨酸激酶2已知能与[[FYN|FYN]]<ref name=pmid9196040>{{cite journal |last=Uddin |first=S |authorlink= |coauthors=Sher D A, Alsayed Y, Pons S, Colamonici O R, Fish E N, White M F, Platanias L C |title=Interaction of p59fyn with interferon-activated Jak kinases |journal=Biochem. Biophys. Res. Commun. |volume=235 |issue=1 |pages=83–8 |publisher= |location = United States| issn = 0006-291X| pmid = 9196040 |doi = 10.1006/bbrc.1997.6741 | bibcode = | oclc =| id = | url = | language = | format = | accessdate = | laysummary = | laysource = | laydate = | quote = |date=June 1997}}</ref>、[[PTPN6|PTPN6]]<ref name=pmid7629131>{{cite journal |doi=10.1074/jbc.270.31.18179 |last=Yetter |first=A |authorlink= |coauthors=Uddin S, Krolewski J J, Jiao H, Yi T, Platanias L C |title=Association of the interferon-dependent tyrosine kinase Tyk-2 with the hematopoietic cell phosphatase |journal=J. Biol. Chem. |volume=270 |issue=31 |pages=18179–82 |publisher= |location = United States| issn = 0021-9258| pmid = 7629131 | bibcode = | oclc =| id = | url = | language = | format = | accessdate = | laysummary = | laysource = | laydate = | quote = |date=August 1995}}</ref>、[[IFNAR1|IFNAR1]]<ref name=pmid9733772>{{cite journal |doi=10.1074/jbc.273.38.24723 |last=Richter |first=M F |authorlink= |coauthors=Duménil G, Uzé G, Fellous M, Pellegrini S |title=Specific contribution of Tyk2 JH regions to the binding and the expression of the interferon alpha/beta receptor component IFNAR1 |journal=J. Biol. Chem. |volume=273 |issue=38 |pages=24723–9 |publisher= |location = United States| issn = 0021-9258| pmid = 9733772 | bibcode = | oclc =| id = | url = | language = | format = | accessdate = | laysummary = | laysource = | laydate = | quote = |date=September 1998}}</ref><ref name=pmid18474601>{{cite journal |last=Kumar |first=K G Suresh |authorlink= |coauthors=Varghese Bentley, Banerjee Anamika, Baker Darren P, Constantinescu Stefan N, Pellegrini Sandra, Fuchs Serge Y |title=Basal ubiquitin-independent internalization of interferon alpha receptor is prevented by Tyk2-mediated masking of a linear endocytic motif |journal=J. Biol. Chem. |volume=283 |issue=27 |pages=18566–72 |publisher= |location = United States| issn = 0021-9258| pmid = 18474601 |doi = 10.1074/jbc.M800991200 | bibcode = | oclc =| id = | url = | language = | format = | accessdate = | laysummary = | laysource = | laydate = | quote = |pmc=2441555 |date=July 2008}}</ref>、[[Ku80|Ku80]]<ref name=pmid10673353>{{cite journal |last=Adam |first=L |authorlink= |coauthors=Bandyopadhyay D, Kumar R |title=Interferon-alpha signaling promotes nucleus-to-cytoplasmic redistribution of p95Vav, and formation of a multisubunit complex involving Vav, Ku80, and Tyk2 |journal=Biochem. Biophys. Res. Commun. |volume=267 |issue=3 |pages=692–6 |publisher= |location = United States| issn = 0006-291X| pmid = 10673353 |doi = 10.1006/bbrc.1999.1978 | bibcode = | oclc =| id = | url = | language = | format = | accessdate = | laysummary = | laysource = | laydate = | quote = |date=January 2000}}</ref>以及[[GNB2L1|GNB2L1]]<ref name=pmid12960323>{{cite journal |last=Usacheva |first=Anna |authorlink= |coauthors=Tian Xinyong, Sandoval Raudel, Salvi Debra, Levy David, Colamonici Oscar R |title=The WD motif-containing protein RACK-1 functions as a scaffold protein within the type I IFN receptor-signaling complex |journal=J. Immunol. |volume=171 |issue=6 |pages=2989–94 |publisher= |location = United States| issn = 0022-1767| pmid = 12960323 | bibcode = | oclc =| id = | url = | language = | format = | accessdate = | laysummary = | laysource = | laydate = | quote = |date=September 2003}}</ref>发生[[蛋白質交互作用|相互作用]]。

==参考文献==
{{reflist|2}}

==延伸阅读==
{{refbegin | 2}}
{{PBB_Further_reading
| citations =
*{{cite journal  | author=Firmbach-Kraft I, Byers M, Shows T, ''et al.'' |title=tyk2, prototype of a novel class of non-receptor tyrosine kinase genes. | url=https://archive.org/details/sim_oncogene_1990-09_5_9/page/1329 |journal=Oncogene |volume=5 |issue= 9 |pages= 1329–36 |year= 1990 |pmid= 2216457 |doi=  }}
*{{cite journal  | author=Partanen J, Mäkelä TP, Alitalo R, ''et al.'' |title=Putative tyrosine kinases expressed in K-562 human leukemia cells. |journal=Proc. Natl. Acad. Sci. U.S.A. |volume=87 |issue= 22 |pages= 8913–7 |year= 1991 |pmid= 2247464 |doi=10.1073/pnas.87.22.8913  | pmc=55070  }}
*{{cite journal  | author=Colamonici O, Yan H, Domanski P, ''et al.'' |title=Direct binding to and tyrosine phosphorylation of the alpha subunit of the type I interferon receptor by p135tyk2 tyrosine kinase. | url=https://archive.org/details/sim_molecular-and-cellular-biology_1994-12_14_12/page/8133 |journal=Mol. Cell. Biol. |volume=14 |issue= 12 |pages= 8133–42 |year= 1994 |pmid= 7526154 |doi=  | pmc=359352  }}
*{{cite journal  | author=Novak U, Harpur AG, Paradiso L, ''et al.'' |title=Colony-stimulating factor 1-induced STAT1 and STAT3 activation is accompanied by phosphorylation of Tyk2 in macrophages and Tyk2 and JAK1 in fibroblasts. |journal=Blood |volume=86 |issue= 8 |pages= 2948–56 |year= 1995 |pmid= 7579387 |doi=  }}
*{{cite journal  | author=Domanski P, Yan H, Witte MM, ''et al.'' |title=Homodimerization and intermolecular tyrosine phosphorylation of the Tyk-2 tyrosine kinase. |journal=FEBS Lett. |volume=374 |issue= 3 |pages= 317–22 |year= 1995 |pmid= 7589562 |doi=10.1016/0014-5793(95)01094-U  }}
*{{cite journal  | author=Yetter A, Uddin S, Krolewski JJ, ''et al.'' |title=Association of the interferon-dependent tyrosine kinase Tyk-2 with the hematopoietic cell phosphatase. |journal=J. Biol. Chem. |volume=270 |issue= 31 |pages= 18179–82 |year= 1995 |pmid= 7629131 |doi=10.1074/jbc.270.31.18179  }}
*{{cite journal  | author=Maruyama K, Sugano S |title=Oligo-capping: a simple method to replace the cap structure of eukaryotic mRNAs with oligoribonucleotides. |journal=Gene |volume=138 |issue= 1-2 |pages= 171–4 |year= 1994 |pmid= 8125298 |doi=10.1016/0378-1119(94)90802-8  }}
*{{cite journal  | author=Trask B, Fertitta A, Christensen M, ''et al.'' |title=Fluorescence in situ hybridization mapping of human chromosome 19: cytogenetic band location of 540 cosmids and 70 genes or DNA markers. |journal=Genomics |volume=15 |issue= 1 |pages= 133–45 |year= 1993 |pmid= 8432525 |doi=10.1006/geno.1993.1021  }}
*{{cite journal  | author=Platanias LC, Uddin S, Yetter A, ''et al.'' |title=The type I interferon receptor mediates tyrosine phosphorylation of insulin receptor substrate 2. |journal=J. Biol. Chem. |volume=271 |issue= 1 |pages= 278–82 |year= 1996 |pmid= 8550573 |doi=10.1074/jbc.271.1.278  }}
*{{cite journal  | author=Gauzzi MC, Velazquez L, McKendry R, ''et al.'' |title=Interferon-alpha-dependent activation of Tyk2 requires phosphorylation of positive regulatory tyrosines by another kinase. |journal=J. Biol. Chem. |volume=271 |issue= 34 |pages= 20494–500 |year= 1996 |pmid= 8702790 |doi=10.1074/jbc.271.34.20494  }}
*{{cite journal  | author=Uddin S, Gardziola C, Dangat A, ''et al.'' |title=Interaction of the c-cbl proto-oncogene product with the Tyk-2 protein tyrosine kinase. |journal=Biochem. Biophys. Res. Commun. |volume=225 |issue= 3 |pages= 833–8 |year= 1996 |pmid= 8780698 |doi= 10.1006/bbrc.1996.1259 }}
*{{cite journal  | author=Zou J, Presky DH, Wu CY, Gubler U |title=Differential associations between the cytoplasmic regions of the interleukin-12 receptor subunits beta1 and beta2 and JAK kinases. |journal=J. Biol. Chem. |volume=272 |issue= 9 |pages= 6073–7 |year= 1997 |pmid= 9038232 |doi=10.1074/jbc.272.9.6073  }}
*{{cite journal  | author=Miyakawa Y, Oda A, Druker BJ, ''et al.'' |title=Thrombopoietin and thrombin induce tyrosine phosphorylation of Vav in human blood platelets. |journal=Blood |volume=89 |issue= 8 |pages= 2789–98 |year= 1997 |pmid= 9108397 |doi=  }}
*{{cite journal  | author=Uddin S, Sher DA, Alsayed Y, ''et al.'' |title=Interaction of p59fyn with interferon-activated Jak kinases. |journal=Biochem. Biophys. Res. Commun. |volume=235 |issue= 1 |pages= 83–8 |year= 1997 |pmid= 9196040 |doi= 10.1006/bbrc.1997.6741 }}
*{{cite journal  | author=Burfoot MS, Rogers NC, Watling D, ''et al.'' |title=Janus kinase-dependent activation of insulin receptor substrate 1 in response to interleukin-4, oncostatin M, and the interferons. |journal=J. Biol. Chem. |volume=272 |issue= 39 |pages= 24183–90 |year= 1997 |pmid= 9305869 |doi=10.1074/jbc.272.39.24183  }}
*{{cite journal  | author=Gauzzi MC, Barbieri G, Richter MF, ''et al.'' |title=The amino-terminal region of Tyk2 sustains the level of interferon alpha receptor 1, a component of the interferon alpha/beta receptor. |journal=Proc. Natl. Acad. Sci. U.S.A. |volume=94 |issue= 22 |pages= 11839–44 |year= 1997 |pmid= 9342324 |doi=10.1073/pnas.94.22.11839  | pmc=23625  }}
*{{cite journal  | author=Suzuki Y, Yoshitomo-Nakagawa K, Maruyama K, ''et al.'' |title=Construction and characterization of a full length-enriched and a 5'-end-enriched cDNA library. |journal=Gene |volume=200 |issue= 1-2 |pages= 149–56 |year= 1997 |pmid= 9373149 |doi=10.1016/S0378-1119(97)00411-3  }}
*{{cite journal  | author=Ahmad S, Alsayed YM, Druker BJ, Platanias LC |title=The type I interferon receptor mediates tyrosine phosphorylation of the CrkL adaptor protein. |journal=J. Biol. Chem. |volume=272 |issue= 48 |pages= 29991–4 |year= 1997 |pmid= 9374471 |doi=10.1074/jbc.272.48.29991  }}
}}
{{refend}}

{{酪氨酸激酶类}}
{{JAK-STAT信号通路}}

[[Category:信号转导|Category:信号转导]]
[[Category:酪氨酸激酶|Category:酪氨酸激酶]]